Ridgetech, Inc. (RDGT) AI Stock Analysis

Ridgetech, Inc. operates as a wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China across two segments: Offline Wholesale and Online Platform. The company distributes prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicine, personal and family care products, and medical devices. Additionally, it offers convenience products such as consumable, seasonal, and promotional items, as well as health food, cosmetics, and daily necessities. Formerly known as China Jo-Jo Drugstores, Inc., the company rebranded to Ridgetech, Inc. in February 2024 and is headquartered in Hangzhou, China.

Ridgetech generated revenue of $132.2M in FY2026, growing 10.2% after a 22.4% decline to $120.0M in FY2025. Gross margin contracted significantly from 20.1% in FY2024 to 3.2% in FY2025 and 3.6% in FY2026. Operating margins have remained negative across the five fiscal years shown, landing at -1.4% in FY2026. Net income was -$1.3M in FY2026, dropping from a net profit of $10.2M in FY2025. Over the trailing twelve months ended June 30, 2026, revenue stood at $132.2M with a profit margin of -0.9% and an operating margin of -2.6%, while quarterly revenue grew 21.4% year-over-year.

As of June 30, 2026, Ridgetech held $17.9M in cash and short-term investments and $22,669 in total debt, resulting in net cash of $17.9M. Shareholders' equity was $40.8M, supported by total assets of $69.0M, a debt-to-equity ratio of 0.00, and a current ratio of 2.31. In FY2026, operating cash flow was -$1.4M and free cash flow was -$1.4M, with capital expenditures of $445.

With a last close of $0.84 on October 16, 2026, Ridgetech has a market cap of $3.0M and an enterprise value of -$14.5M. The stock trades at a forward P/E of 1.1x, a price-to-sales of 0.0x, and an EV/EBITDA of 233.1x. By comparison, the median of its US-listed Healthcare peers trades at a forward P/E of 17.3x, a price-to-sales of 4.1x, and an EV/EBITDA of 12.0x. RDGT shares have traded between a 52-week low of $0.67 and a 52-week high of $417.00, with a beta of -0.10, while the S&P 500 (SPY) returned 16.8% over the past year.

Ridgetech had zero EPS beats over the last 4 quarters. The company's next earnings date is October 30, 2026. Institutional investors hold 3.8% of the stock, while insiders own 0.4%, and short interest accounts for 7.4% of the float.

This page is an AI-written research summary of Ridgetech, Inc. (RDGT). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: RDGT income statement, RDGT balance sheet, RDGT key metrics, RDGT chart. See the RDGT stock overview for the latest quote and news.